Locally Advanced or Metastatic Non-small Cell Lung Cancer

DBCOND0055934Respiratory Tract Diseases Thoracic and Respiratory Tract Neoplasms

Locally Advanced or Metastatic Non-small Cell Lung Cancer is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as: Locally Advanced or Metastatic NSCLC · Locally Advanced or Metastatic Non Small Cell Lung Cancer · Locally Advanced/ Metastatic NSCLC · Metastatic or Locally Advanced NSCLC
Classified under: Respiratory Tract Diseases
Thoracic and Respiratory Tract Neoplasms
Indicated drugs: Repotrectinib

What you can answer from here — as of October 22, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

27Clinical trialsPhase, status and sponsor resolved per trial

8Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Locally Advanced or Metastatic Non-small Cell Lung Cancer share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account